Oxford BioMedica PLC (OXB) — Net Asset Momentum
Oxford BioMedica PLC (OXB) recorded a net asset momentum of -22.3% as of December 2024, with net assets of GBX60.49 Million GBX. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See OXB cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Oxford BioMedica PLC Net Asset Momentum (1996–2024)
This chart tracks Oxford BioMedica PLC's year-over-year net asset growth across 30 annual reporting periods from 1996 to 2024. The most recent momentum reading is -22.3%, with net assets of GBX60.49 Million GBX as of December 2024. Read OXB total debt and obligations for a breakdown of total debt and financial obligations.
Annual Net Asset History for Oxford BioMedica PLC (1996–2024)
The table below shows the complete annual net asset history for Oxford BioMedica PLC from 1996 to 2024, covering 30 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see OXB market cap overview.
| Year | Net Assets (GBX) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | GBX60.49 Million | GBX231.64 Million | GBX171.16 Million | ▼ -22.3% |
| 2023 | GBX77.83 Million | GBX252.34 Million | GBX174.51 Million | ▼ -67.0% |
| 2022 | GBX236.19 Million | GBX460.18 Million | GBX223.99 Million | ▲ +26.1% |
| 2021 | GBX187.34 Million | GBX237.23 Million | GBX49.89 Million | ▲ +66.2% |
| 2020 | GBX112.75 Million | GBX183.93 Million | GBX71.18 Million | ▲ +49.1% |
| 2019 | GBX75.63 Million | GBX122.93 Million | GBX47.30 Million | ▲ +117.7% |
| 2018 | GBX34.74 Million | GBX112.40 Million | GBX77.66 Million | ▲ +465.3% |
| 2017 | GBX6.15 Million | GBX65.40 Million | GBX59.26 Million | ▼ -51.3% |
| 2016 | GBX12.62 Million | GBX56.94 Million | GBX44.33 Million | ▲ +15.8% |
| 2015 | GBX10.89 Million | GBX51.85 Million | GBX40.96 Million | ▼ -52.7% |
| 2014 | GBX23.04 Million | GBX33.80 Million | GBX10.77 Million | ▲ +158.9% |
| 2013 | GBX8.90 Million | GBX13.64 Million | GBX4.75 Million | ▼ -54.7% |
| 2012 | GBX19.64 Million | GBX24.42 Million | GBX4.78 Million | ▲ +10.5% |
| 2011 | GBX17.77 Million | GBX26.09 Million | GBX8.32 Million | ▲ +53.1% |
| 2010 | GBX11.61 Million | GBX25.64 Million | GBX14.04 Million | ▼ -44.7% |
| 2009 | GBX20.98 Million | GBX43.95 Million | GBX22.97 Million | ▼ -9.9% |
| 2008 | GBX23.27 Million | GBX43.12 Million | GBX19.85 Million | ▼ -27.1% |
| 2007 | GBX31.93 Million | GBX61.16 Million | GBX29.23 Million | ▲ +6.1% |
| 2006 | GBX30.09 Million | GBX35.54 Million | GBX5.45 Million | ▼ -35.4% |
| 2005 | GBX46.60 Million | GBX49.24 Million | GBX2.64 Million | ▲ +76.7% |
| 2004 | GBX26.38 Million | GBX28.58 Million | GBX2.21 Million | ▼ -25.1% |
| 2003 | GBX35.21 Million | GBX36.71 Million | GBX1.50 Million | ▲ +37.9% |
| 2002 | GBX25.53 Million | GBX26.79 Million | GBX1.26 Million | ▼ -31.9% |
| 2001 | GBX37.51 Million | GBX39.26 Million | GBX1.76 Million | ▲ +189.0% |
| 2000 | GBX12.98 Million | GBX14.32 Million | GBX1.34 Million | ▲ +241.4% |
| 1999 | GBX3.80 Million | GBX4.60 Million | GBX801.00K | ▼ -20.2% |
| 1998 | GBX4.76 Million | GBX5.24 Million | GBX480.00K | ▲ +72.4% |
| 1997 | GBX2.76 Million | GBX3.20 Million | GBX441.00K | ▲ +145.4% |
| 1996 | GBX1.12 Million | GBX1.25 Million | GBX126.00K | ▲ +0.0% |
| 1996 | GBX1.12 Million | GBX1.25 Million | GBX126.00K | — |